Trial Profile
An open-label, two-period, sequential trial to study the effects of the co-administration of single and multiple doses of rifampin on the pharmacokinetics and safety of elagolix in healthy premenopausal females
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Elagolix (Primary) ; Rifampicin
- Indications Endometriosis; Pelvic pain
- Focus Adverse reactions; Pharmacokinetics
- 20 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics